@article{01H1YBDWQ8VMJBW1EY4E1TBMY9,
  abstract     = {{Background and Objectives : Owing to their extensive clinical and molecular heterogeneity, hereditary neurologic diseases in adults are difficult to diagnose. The current knowledge about the diagnostic yield and clinical utility of exome sequencing (ES) for neurologic diseases in adults is limited. This observational study assesses the diagnostic value of ES and multigene panel analysis in adult-onset neurologic disorders.

Methods : From January 2019 through April 2022, ES-based multigene panel testing was conducted in 1,411 patients with molecularly unexplained neurologic phenotypes at the Ghent University Hospital. Gene panels were developed for ataxia and spasticity, leukoencephalopathy, movement disorders, paroxysmal episodic disorders, neurodegeneration with brain iron accumulation, progressive myoclonic epilepsy, and amyotrophic lateral sclerosis. Single nucleotide variants, small indels, and copy number variants were analyzed. Across all panels, our analysis covered a total of 725 genes associated with Mendelian inheritance.

Results : A molecular diagnosis was established in 10% of the cases (144 of 1,411) representing 71 different monogenic disorders. The diagnostic yield depended significantly on the presenting phenotype with the highest yield seen in patients with ataxia or spastic paraparesis (19%). Most of the established diagnoses comprised disorders with an autosomal dominant inheritance (62%), and the most frequently mutated genes were NOTCH3 (13 patients), SPG7 (11 patients), and RFC1 (8 patients). 34% of the disease-causing variants were novel, including a unique likely pathogenic variant in APP (Ghent mutation, p.[Asn698Asp]) in a family presenting with stroke and severe cerebral white matter disease. 7% of the pathogenic variants comprised copy number variants detected in the ES data and confirmed by an independent technique.

Discussion : ES and multigene panel testing is a powerful and efficient tool to diagnose patients with unexplained, adult-onset neurologic disorders.}},
  articleno    = {{e200071}},
  author       = {{Schuermans, Nika and Verdin, Hannah and Ghijsels, Jody and Hellemans, Madeleine and Debackere, Elke and Bogaert, Elke and Symoens, Sofie and Naesens, Leslie and Lecomte, Elien and Crosiers, David and Bergmans, Bruno and Verhoeven, Kristof and Poppe, Bruce and Laureys, Guy and Herdewyn, Sarah and Van Langenhove, Tim and Santens, Patrick and De Bleecker, Jan and Hemelsoet, Dimitri and Dermaut, Bart and for Program for Undiagnosed Rare Diseases (UD-PrOZA), [missing]}},
  issn         = {{2376-7839}},
  journal      = {{NEUROLOGY-GENETICS}},
  keywords     = {{Genetics (clinical),Neurology (clinical),FREQUENT CAUSE,VARIANTS,PIPELINE,UTILITY,REPEAT}},
  language     = {{eng}},
  number       = {{3}},
  pages        = {{11}},
  title        = {{Exome sequencing and multigene panel testing in 1,411 patients with adult-onset neurologic disorders}},
  url          = {{http://doi.org/10.1212/nxg.0000000000200071}},
  volume       = {{9}},
  year         = {{2023}},
}

Altmetric

View in Altmetric

Web of Science

Times cited: